Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Celladon Mydicar Drug Receives FDA Fast Track Status
Dec. 14, 2011
Celladon’s investigational product candidate, Mydicar, has been granted fast track designation by the FDA, used to treat patients with advanced heart failure.
Pharmaceutical Business Review
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing